“Tirzepatide Across the Cardiovascular Continuum From HFpEF to Cardiorenal Protection With a Dual GLP-1 GIP Agonist”. Diabzen 4, no. 21 (July 7, 2026): 42–43. Accessed September 17, 2026. https://www.thediabzen.com/index.php/d/article/view/64.